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INTRODUCTION
Idiopathic granulomatous mastitis (IGM) is a benign breast 
disease that was first described by Kessler and Wolloch in 1978 
[1]. A rare inflammatory condition of the breast, it usually   
occurs in young parous women with a history of breast-feed-
ing [1-6]. The most common clinical presentation is a firm, 
unilateral, and discrete breast mass that is often associated with 
inflammation of the overlying skin. In ≥50% of reported cases, 
the initial diagnosis was considered malignant or was suspected 
to be breast cancer. Other causes of mammary granuloma 
formation must be excluded before a confirmative diagnosis 
can be made, including sarcoidosis, Wegener’s granulomatosis, 
tuberculosis, and a fungal infection because they require com-
pletely different treatments. Microbiological investigation is, 
therefore, very important. Cytological features can be difficult 
to distinguish from those of carcinoma and other granuloma-
tous mastitis such as tuberculosis of the breast.
Tuberculous mastitis (TM) is an uncommon disease that is 
often difficult to differentiate from IGM and breast cancer 
when it presents as a lump. Breast tuberculosis should be con-
sidered a differential diagnosis in people with clinically suspi-
cious breast lumps in high-risk populations or endemic areas. 
Use of corticosteroids and surgical wide excision of the lesions 
have been reported for the treatment of IGM. TM is an impor-
tant differential diagnosis because of the implications of corti-
costeroid therapy.
In this study, we compared the clinicopathological features, 
management, and outcomes of IGM and TM in an effort to 
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Purpose: Idiopathic granulomatous mastitis (IGM) is a rare chron-
ic inflammatory disease of unknown etiology. The diagnosis of 
IGM requires that other granulomatous lesions in the breast be 
excluded. Tuberculous mastitis (TM) is also an uncommon   
disease that is often difficult to differentiate from IGM. The pur-
pose of this study is to develop a new algorithm for the differen-
tial diagnosis and treatment of IGM and TM. Methods: Medical 
records of 68 patients (58 with IGM and 10 with TM) between 
July 1999 and February 2009 were retrospectively reviewed.   
Results: The mean age of the patients was 33.5 (IGM) and 40 
(TM) years (p=0.018). The median follow-up was 84 months. Of 
the total 10 patients with TM, 5 patients had a history of pulmon- 
ary tuberculosis. The most common symptoms of the diseases 
were breast lump and pain. However, axillary lymphadenopathy 
was more seen in TM (50%) compared to IGM (20.6%) (p=0.048). 
TM showed more cancer-mimicking findings on radiologic study 
(p=0.028). In IGM, 48 patients (82.7%) underwent surgical wide 
excision and 21 patients (36.2%) were managed with corticoster- 
oid therapy and antibiotics. All of the TM patients received anti-
tuberculosis medications and 9 patients (90%) underwent wide 
excision. The mean treatment duration was 2.8 months in IGM 
and 8.4 months in TM. Recurrence developed in 5 patients (8.6%) 
in IGM and 1 patient (10%) in TM. Conclusion: This study shows 
different characteristics between IGM and TM. The IGM patients 
were younger and had more mastalgia symptoms than the TM 
patients. Axillary lymphadenopathy was seen more often in TM 
patients. Half of the TM patients had pulmonary tuberculosis or 
tuberculosis lymphadenitis. Surgical wide excision might be both 
therapeutic and useful for providing an exact diagnosis. 
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determine modalities for the differential diagnosis.
METHODS
This study enrolled 68 IGM and TM patients diagnosed at 
one university hospital between July 1999 and February 2009. 
Of the patients, 58 patients had IGM and 10 patients had TM. 
After obtaining approval from the Institutional Review Board 
(AJIRB-MED-MDB-11-092), the following clinicopathological 
data were retrospectively collected from the medical records: 
patient demographics; pertinent history; clinical features; ra-
diographic, histological, and microbiological results; treatment 
modalities; and follow-up recurrence data.
The histological diagnosis of granulomatous mastitis was 
made when a granulomatous reaction was centered on lobules 
and neither caseous necrosis nor any specific organisms was 
present. All slides were treated with hematoxylin and eosin 
and special stains such as Gram, Ziehl-Neelson stain for   
Mycobacterium tuberculosis, and periodic acid Schiff for fungal 
infections by one pathologist. Acid-fast bacillus (AFB) culture 
and polymerase chain reaction (PCR) for M. tuberculosis were 
also performed. PCR was performed using paraffin blocks.
Mean follow-up was 11.71 months and 21 months in IGM 
and TM, respectively.
Statistical analysis was performed using SPSS version 15.0 
(SPSS Inc., Chicago, USA) by the biomedical informatics team. 
Differences between groups were evaluated using Pearson’s χ
2 
test or Fisher’s exact test. A p-value <0.05 was considered sig-
nificant. 
RESULTS
Clinical characteristics
The patients were 17-65 years of age. The median age in the 
IGM and TM groups was 33.48 years and 40 years, respective-
ly. Patients with IGM had significantly earlier onset than   
patients with TM (p=0.018). Most patients (97%) were of 
reproductive age. Six patients with IGM had a history of lacta-
tion history within 12 months prior to presentation and 1  
patient with IGM had a history of oral contraceptive pill use 
(Table 1).
No patients with IGM had a history of connective tissue 
disease, sarcoidosis, tuberculosis, or other infectious granulo-
matous diseases. In contrast, 5 patients with TM (50%) had a 
history of pulmonary tuberculosis. The chief complaint was a 
breast lump and pain in both groups. There was no difference 
in the incidence of breast laterality. One patient with IGM 
presented with bilateral breast involvement. 
The most common presenting symptoms of IGM were a 
breast mass (52 patients, 89.6%), mastalgia (49 patients, 84.4%), 
and overlying skin erythema (39 patients, 67.2%). In TM, a 
breast mass (7 patients, 70%), breast pain (5 patients, 50%), 
and axillary lymphadenopathy (5 patients, 50%) were noted. 
Significantly more patients with IGM complained of mastal-
gia (p=0.013). Axillary lymphadenopathy was more frequent 
in the patients with TM (p=0.048).
Radiologic evaluation
All 10 patients with TM and 57 patients with IGM under-
went radiographic examination. Five patients with TM under-
went both ultrasonography (US) and mammography (MMG). 
Five patients underwent US alone due to breast pain. Twenty-
six patients with IGM underwent MMG and 57 underwent 
US. The one patient who did not undergo US already had an 
abscess drainage tube installed in other hospital. Radiologic 
findings were confirmed through cross-checking of 3 radiolo-
gists.
In patients with IGM, MMG revealed an asymmetric den-
sity with no distinct margins in 13 patients and an ill-defined 
mass in 7 patients. Axillary lymph node (LN) enlargement 
was detected using MMG in 2 patients with TM (Table 2). US 
examination showed a heterogeneous hypoechoic lesion in 26 
patients with IGM and 3 patients with TM. An ill-defined hy-
poechoic mass was seen in 14 patients with IGM and in 5 pa-
tients with TM (Figure 1). Multifocal abscess cavities were 
seen in 16 patients with IGM. Axillary LN enlargement was 
present in 8 patients (80%) with TM. Clinical and radiological 
findings before biopsy suggested a suspicious malignant neo-
plasm in 7 patients with TM (70%) versus 17 patients with IGM 
(29.8%).
Table 1. The clinical characteristics of patients with IGM and TM
Characteristic
IGM (n=58)  
No. (%)
TM (n=10)  
No. (%)
p-value
Age (yr)* 33.5 (17-47) 40 (21-65) 0.018
Symptom
   Breast lump 52 (89.6) 7 (70) 0.120
   Mastalgia 49 (84.4) 5 (50) 0.013
   Skin change 39 (67.2) 3 (30) 0.860
   Axillary lymphadenopathy 12 (20.6) 5 (50) 0.048
Location 0.886
   Right 26 (44.8) 5 (50)
   Left 31 (53.5) 5 (50)
   Bilateral 1 (1.7) 0 (0)
Lactation (last 12 mo) 6 (10.3) 0 (0) 0.581
Oral pill 1 (1.7) 0 (0)
Tuberculosis history 0 (0) 5 (50) <0.001
IGM=idiopathic granulomatous mastitis; TM=tuberculous mastitis.
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Diagnostic and histopathological evaluation
Fine-needle aspiration biopsy (FNAB) was performed in 24 
patients with IGM and 6 patients with TM but was diagnostic 
in only 6 (25%) and 1 (16.6%), respectively. FNAB results were 
inconclusive in 18 (75%) patients with IGM and 5 (83.4%) pa-
tients with TM because of insufficient materials or nonspecific 
inflammatory findings. All women with an inconclusive FNAB 
underwent US-guided core biopsy or surgical excisional biop-
sy to obtain a definitive diagnosis. Twenty-three women had 
an US-guided core biopsy, of which 17 (73.9%) were diagnos-
tic: 15 patients with IGM (75.0%) and 2 patients with TM 
(66.7%). The remaining 44 women underwent excisional bi-
opsies that were subsequently confirmed the IGM and TM 
diagnoses.
In 58 patients, IGM was the final diagnosis and was charac-
terized microscopically by the presence of lobulocentric non-
necrotizing granulomas (clusters of epithelioid histiocytes) in 
which no microorganisms or features of other pathologic en-
Figure 1. Ultrasonography of idiopathic granulomatous mastitis and tuberculous mastitis. (A) Idiopathic granulomatous mastitis: ill-defined hypoechoic 
mass with echogenic debridement. (B) Idiopathic granulomatous mastitis: finger-like projection. (C, D) Tuberculous mastitis: heterogeneous, hypoechoic 
masses with internal calcification.
Table 2. The radiologic findings of patients with IGM and TM
Radiologic findings*
IGM 
No. (%)
TM 
No. (%)
p-value
Mammographic findings  
   No. of patients 26   5
   Normal   4 (15.4)   1 (20) 1.000
   Focal asymmetric increased density 13 (50.0)   1 (20) 0.344
   Ill-defined Mass   7 (26.9)   2 (40) 0.613
   Axillar LN enlargement   9 (34.6)   2 (40) 1.000
   Calcification 2 (7.7) 0 (0) 1.000
   BI-RADS category 4-5   5 (19.3)   2 (40) 0.562
Ultrasonography findings
   No. of patients 57 10
   Heterogeneous hypoechoic lesion 26 (45.6)   3 (30) 0.495
   Ill-defined hypoechoic mass 14 (24.6)   5 (50) 0.132
   Multifocal abscess cavity 16 (28.0) 0 (0) 0.102
   Axillar LN enlargement 17 (29.8)   8 (80) 0.004
   BI-RADS category 4-5 17 (29.8)   7 (70) 0.028
IGM=idiopathic granulomatous mastitis; TM=tuberculous mastitis; LN=lymph 
node; BI-RADS=Breast Imaging Reporting and Data System.
*Radiologic findings represent sum of all findings obtained from each patient.
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tities were identified (Figure 2). Additional microscopic findings 
included lymphocytes, plasma cells, neutrophils, and giant cells. 
The inflammation often extended into adjacent perilobular 
and interlobular tissues. Culture for alcohol AFB was done in 
patients with discharge. PCR was performed in 13 patients, 
including 9 with IGM and 4 with TM, the latter of which re-
sulted in confirmative diagnoses. Except for 4 PCR-confirmed 
cases, 3 of 6 cases were AFB-positive in the breast tissue and     
2 cases were AFB-positive in the enlarged axillary LN. One 
patient with TM in 2007 who was AFB-negative and treated 
with anti-tuberculosis medicine after clinical diagnosis was 
PCR-positive when the test was run again at the time of this 
writing.
Treatment and outcome
Forty-five (77.6%) patients with IGM received antibiotics 
for the local infection at the time of presentation or preopera-
tively. The type, dosage, and duration of antibiotic treatment 
varied and were dependent on the degree of patient presenta-
tion and the culture results. All of the patients with TM received 
anti-tuberculous therapy comprising rifampicin (450 mg), 
isoniazid (400 mg), pyrazinamide (1,500 mg), and ethambutol 
(800 mg) for 2 months followed by rifampicin, isoniazid, and 
ethambutol for another 4-7 months. Extended treatment for 
10-14 months was needed in 3 (30%) of the 10 patients, all of 
whom had discontinued drug therapy and had recurrent or 
persistent symptoms. Twenty-one patients (36.2%) with IGM 
received corticosteroid treatment. Prednisolone was adminis-
tered at a dose of ≤30 mg and continued until complete remis-
sion was achieved, followed by a tapering schedule of usually 
30, 20, 10, and 5 mg. Medication was administered once in the 
early morning for steroid hormones to match the physiologic 
diurnal rhythm. The mean duration of steroid treatment was 
28 days (7-120 days).
Most of the patients in both groups underwent surgical 
management. Surgical procedures included incision and drain-
age and wide local excision. None of the patients who received 
incision and drainage experienced improved symptoms other 
than early symptom relief. Forty-eight patients with IGM 
(82.8%) and 9 patients with TM (90.0%) required surgical 
wide local excision. The mean treatment duration was 2.8 
months (0.2-12 months) for patients with IGM and 8.4 months 
(1-14 months) for patients with TM. Compared with IGM, 
patients with TM had significantly longer treatment durations 
(p<0.001). Mean follow-up was 11.71 months and 21 months 
in patients with IGM and patients with TM, respectively.
Recurrence developed in 5 (8.6%) patients with IGM. The 
mean age was 34.2 years and the mean mass size was 2.5 cm. 
Breast pain developed 2-5 months after excision in 3 patients 
with IGM, all of whom were treated with steroid therapy. In 
the other 2 cases of recurrence, a painful breast lump appeared 
after steroid therapy and was successfully treated with wide 
local excision. Only one patient with TM experienced recur-
rence, which consisted of a mass lesion with axillary LN enlarge-
ment that appeared 22 months after the patient discontinued 
the anti-tuberculous therapy. The recurrence was successfully 
treated by restarting of the anti-tuberculous therapy. 
DISCUSSION
IGM a rare benign breast disease [1,2]. Few articles exist in 
the literature, most of which are case reports and small series 
[7-10]. Most patients are young parous women, but males may 
also be affected [2,11]. The age at diagnosis is generally 20-50 
years; however, patients 11 and 83 years of age were reported 
[4,12]. IGM commonly occurs in patients with a history of re-
cent pregnancy and lactation [2,3]. This finding was reflected 
in our study (mean patient age, 33.48 years; range, 17-47 years). 
A B C
Figure 2. Pathological characteristics of a patient with idiopathic granulomatous mastitis and tuberculous mastitis. (A) Idiopathic granulomatous 
mastitis: lobulocentric granulomas (H&E stain, ×200). Inlet: epithelioid granulomas and multinucleated giant cells were gathered around a glandular 
structure (H&E stain, ×400). (B) Tuberculous mastitis: biopsy specimen showing granulomatous inflammation with microabscess in the center (H&E 
stain,×200). Inlet: histopathological examination of the specimen revealed granulomas with caseous necrosis (H&E stain,  ×400). (C) Tuberculous 
mastitis:  acid-fast bacilli (Ziehl-Neelsen stain, ×1,000). IdiopathicGranulomatousMastitisandTuberculousMastitis 115
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The etiology of IGM is not clear. Many agents, such as local ir-
ritants, viruses, mycotic, parasitic infections, hyperprolac-
tinemia, diabetes mellitus, smoking, and alfa-1 antitrypsin de-
ficiency, have been considered, but an autoimmune reaction is 
most favored [1,2,13,14]. Also, the observed similarity between 
IGM and autoimmune diseases such as granulomatous thy-
roiditis, granulomatous prostatitis, granulomatous orchitis, 
and response to steroid treatment is compatible with the auto-
immune hypothesis [1]. Extravasated lactational secretions 
may elicit a local granulomatous response with lymphocyte 
and macrophage migration. Extravasations of luminal secre-
tions may occur secondary to local trauma or infection caus-
ing damage to the ductal epithelium [2,4,15]. A chemical- 
induced reaction associated with use of oral contraceptive 
pills has also been suggested [5,16]. In our data, only 1 patient 
had previously used contraceptive pills, while 6 patients had 
lactated in the previous 12 months.
In the diagnosis of IGM, the differential diagnosis must   
include other granulomatous diseases such as TM, sarcoidosis, 
Wegener’s granulomatosis, and breast cancer [1,15,17,18]. TM 
must be especially considered since it increases in endemic     
regions. In the western countries, TM is rare and is associated 
with 0.1% of all breast lesions. In developing countries like  
India, it constitutes approximately 3% of treatable breast con-
ditions. Physicians must also be cautious when examining   
patients from high-risk populations or endemic areas. Recently, 
Bani-Hani et al. [16] stated that the largest reported series of 
IGM came from developing countries. As a result, they sug-
gested that IGM might reflect TM underdiagnosis. The cyto-
morphologic pattern seen in TM is indistinguishable from 
that seen in IGM. Since it is not always possible to detect acid-
fast bacilli in histological sections of TM, accurate diagnosis 
can safely be made only when additional clinical data are pres-
ent. IGM and TM have similar clinical symptoms, including   
a solitary breast mass, chronic draining sinus tracts, or an       
abscess cavity [6,11,19]. A breast mass is the most common 
presentation in IGM. The mass will sometimes penetrate the 
breast skin or the underlying pectoralis muscle. Nipple retrac-
tion, sinus formation, and axillary lymphadenopathy may be 
seen in IGM patients [11,13,14,20]. These finding were also 
observed in TM and breast cancer. In this study, patients in 
both disease groups presented most commonly with a palpa-
ble breast mass, breast pain, and overlying erythema. IGM is 
usually unilateral, although bilateral involvement has been   
reported [2,15,21,22]. In this study, unilateral involvement of 
breast was seen at initial presentation and no difference was 
detected between the right and left breasts or breast quadrants 
in all patients but one.
Breast US and MMG in IGM are used primarily to rule out 
other breast diseases, especially breast carcinoma [16]. In this 
study, the MMG reports of 1 patient with TM and 4 patients 
with IGM were suspicious of breast carcinoma. Asymmetric 
diffusely increased density of the fibroglandular tissue was the 
most frequent nonspecific mammographic finding in our study. 
This finding can be seen in normal breast or other types of 
diseases, including cancer. On the other hand, no clear mam-
mographic abnormalities were found in 5 patients. Most of the 
US evaluations revealed ill-defined, irregularly shaped areas of 
echogenicity. These findings are in keeping with reports in the 
literature [2,6,16]. Corresponding US of these 7 patients with 
TM showed various features: an irregular hypoechoic mass le-
sion in 5 cases, hypoechoic nodular structures in 3 cases, and 
enlarged axillary LN in 8 cases. These are also the most com-
mon US findings for breast carcinoma. For this reason, cyto-
logical and histological examinations are required in addition 
to imaging modalities for diagnostic accuracy. 
Because clinical and imaging studies of IGM and TM are 
nonspecific, definitive diagnosis is made using histopathology 
[13]. Among the large series describing the FNAB features of 
IGM in the literature, the usefulness of FNAB in IGM has 
been debated, with some authors confirming the useful role of 
FNAB [23] and others concluding that the various causes of 
granulomatous inflammation cannot be confidently differen-
tiated by FNAB [24]. But FNAB is still an option for tissue 
sampling because it is more easily available and provides faster 
results than core biopsy [24]. FNAB may also be helpful in 
differentiating malignancy from an inflammation. The cyto-
pathology of TM reveals epithelioid histiocytes, Langhan’s   
giant cells, granulomas, and caseous necrosis. Demonstration 
of AFB insections or positive culture for acid-fast bacilli con-
firms the diagnosis of TM. The presence of neutrophils is not 
common in TM. The pathological criteria for the diagnosis of 
IGM include granulomatous inflammation with multinucle-
ated giant cells, epithelioid histiocytes, and occasional features 
of fat necrosis, abscesses, sinus tract, and eosinophils. It is   
centered on lobules, but extensive inflammation may obliter-
ate this feature. Minor ductal and periductal inflammation is 
usually seen. A predominantly neutrophilic background and 
the absence of necrosis favor a diagnosis of IGM. It should be 
considered when high numbers of epithelioid histiocytes are 
seen. However, FNAB may not always differentiate between 
IGM and other granulomatous diseases of the breast, and a   
final diagnosis may require histological samples, negative   
microbiological investigations, and clinical correlations. In 
our study, we found US-guided core biopsy to be more accu-
rate because they showed the tissue architecture. Core biopsy 
was diagnostic in 75% of IGM patients who underwent US-
guided biopsy, whereas only 25% of the FNAB procedures 116  HeeRiNaSeo,etal.
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were diagnostic. Common causes of FNAB failure included 
insufficient material and nonspecific findings (e.g., fat necro-
sis, abscess). The use of PCR in the diagnosis of TM is less of-
ten reported, mostly as a tool to distinguish TM from other 
forms of granulomatous mastitis in selected reports [25]. Our 
experience shows that PCR was performed in 4 patients of TM 
and all of these had confirmed diagnosis.
The optimal management of IGM remains controversial 
[4,11,26]. Treatment alternatives have been described in very 
few articles. In this study, surgical excision and antibiotics were 
the primary treatment modalities. There are limited data on 
the use of antibiotic therapy for the treatment of IGM in the 
literature [2]. However, many patients developed cellulitis, ab-
scesses, and open draining sinuses. In these cases, initial em-
piric treatment with antibiotics should be administered. Cul-
tures of all aspirate and biopsy samples should be obtained 
and can appropriately direct antimicrobial therapy. In this 
study, only 1 IGM sample was culture-positive for Staphylococ-
cus epidermidis, while all of other IGM samples were culture- 
negative. One case of TM was culture-positive for Mycobacte-
ria. Our experience shows that wide surgical excision was 
associated with a low recurrence. Surgical excision can be 
therapeutic as well as useful in providing an exact diagnosis. 
After excision, if there is no delayed wound healing, infection, 
or recurrence, further therapy is not needed for IGM. Limited 
surgical excisions may lead to recurrence [16]. Wide surgical 
excisions have been associated with lower recurrence and 
complication rates [2].
Corticosteroids comprise the treatment of choice as conser-
vative management [27]. Satisfactory results have been report-
ed with high doses of prednisone. Steroids have been used  
either after excision or before surgery. For complicated and 
resistant cases, steroids should be administered after excision. 
In 18 of our cases, we administered steroid therapy after sur-
gery. Corticosteroid therapy of prednisolone 2-30 mg⁄day is 
recommended for at least 6 weeks and should be continued 
until complete remission [17]. In this study, 530 mg predniso-
lone was administered and continued until complete remis-
sion was achieved, followed by a tapering schedule. The mean 
duration of steroid treatment was 28 days. Corticosteroids 
may exacerbate infectious diseases of the breast; therefore,   
exclusion of an infectious etiology was essential before actual 
administration of steroid treatment in all of our cases. It is   
important that TM be fully resolved prior to steroid treatment, 
particularly in endemic areas. Furthermore, the side effects of 
steroid therapy include glucose intolerance and cushingoid 
features. None of our patients who received steroid therapy 
showed side effects. In the literature review, different recur-
rence rates (range, 5.5-50%) are reported after excision [4,14]. 
In this study, recurrence developed in 5 (8.6%) patients.
Figure 3. Treatment algorithm for the management of idiopathic granulomatous mastitis and tuberculous mastitis.
I&D=incision and drainage; IGM=idiopathic granulomatous mastitis; TM=tuberculous mastitis.
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IGM and TM are rare inflammatory disease of the breast 
that tend to occur in young parous women. The disease pro-
cess most commonly presents as a solitary breast mass. Breast 
carcinoma and other inflammatory diseases of the breast must 
be ruled out prior to treatment. IGM can be difficult to distin-
guish from TM by clinical symptoms and radiologic findings. 
Differential diagnosis is important because they require abso-
lutely different treatments. This study shows clinical differenc-
es between IGM and TM: 1) Patients with IGM tended to be 
younger than TM (mean age, 33.5 and 40 years; p=0.018); 2) 
Axillary lymphadenopathy was seen more in TM than IGM 
(50% and 20.6%, p=0.048); 3) Mastalgia was more common 
in patients with IGM (84.4% and 50%, p=0.013); 4) In radi- 
ologic finding, TM was more cancer mimicking (p=0.028); 5) 
Half of the patients with TM had a history of pulmonary tuber-
culosis or tuberculosis lymphadenitis. For this reason, check 
the chest X-ray and pay close attention to a patient’s medical 
history.
The diagnosis of IGM must be based on a multidisciplinary 
approach. A few of these cases were diagnosed clinically and 
radiologically before FNAB and core biopsy were performed, 
which emphasizes the recognition among surgeons, radiolo-
gists, and pathologists of this unusual but distinctive disorder. 
Increased recognition of these diseases will improve their un-
derstanding and management of them. Appropriate applica-
tions of surgical excision, steroid therapy, and combination 
with antibiotics if there is evidence of infection, are the most 
preferred treatment modality (Figure 3).
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